Cypre partners with biopharma teams advancing immunotherapy, bispecifics, and next-generation targeted agents.
Contact us to explore MOA collaborations, biomarker discovery, or strategic platform
deployment.
Partner with Cypre to co-develop translationally validated, IND-ready insights using our complete 3D tumor organoid platform. From immune profiling to custom panels, we’re built for collaboration.